Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury

Blood Purification

Volumn 26, Issue 1, 2008, Pages 30-35

  House, Andrew A ^a   Ronco, Claudio ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Acute kidney injury; Extracorporeal blood purification; Hemoadsorption; Hemofiltration; Immunomodulation; RIFLE; Sepsis; Septic inflammatory response syndrome

Indexed keywords

ACID BASE BALANCE; CONFERENCE PAPER; ELECTROLYTE BALANCE; EXTRACELLULAR SPACE; HEMADSORPTION; HEMODIALYSIS; HEMOFILTRATION; IMMUNOMODULATION; INFLAMMATION; KIDNEY FUNCTION; KIDNEY INJURY; MEDIATOR; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENAL PROTECTION; SEPSIS;

ACUTE DISEASE; HEMOFILTRATION; HUMANS; INFLAMMATION; KIDNEY; PLASMA EXCHANGE; PLASMAPHERESIS; RENAL DIALYSIS; SEPSIS;

EID: 38049071071     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110560     Document Type: Conference Paper

References (41)

1. Kellum JA, Levin N, Bouman C, Lameire N: Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002;8:509-514.
2. Bellomo R, Kellum JA, Ronco C: Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med 2007;33:409-413.
3. Uchino S, Bellomo R, Goldsmith D, et al: An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006;34:1913-1917.
4. Bernard GR, Artigas A, Brigham KL, et al: Report of the American-European Consensus Conference on Acute Respiratory Distress Syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care 1994;9:72-81.
5. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-1655.
6. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-150.
7. Ronco C, Tetta C, Mariano F, et al: Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 2003;27:792-801.
8. Yasuda H, Yuen PS, Hu X, et al: Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 2006;69:1535-1542.
9. Chen HW, Kuo HT, Chai CY, et al: Pretreatment of curcumin attenuates coagulopathy and renal injury in LPS-induced endotoxemia. J Endotoxin Res 2007;13:15-23.
10. Gupta A, Rhodes GJ, Berg DT, et al: Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. Am J Physiol Renal Physiol 2007;293:F245-F254.
11. Gotloib L, Barzilay E, Shustak A, Lev A: Sequential hemofiltration in non-oliguric high capillary permeability pulmonary edema of severe sepsis: preliminary report. Crit Care Med 1984;12:997-1000.
12. De Vriese AS, Colardyn FA, Philippe JJ, et al: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999;10:846-853.
13. De Vriese AS, Vanholder RC, Pascual M, et al: Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies? Intensive Care Med 1999;25:903-910.
14. Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30.
15. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
16. Costanzo MR, Guglin ME, Saltzberg MT, et al: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007;49:675-683.
17. Huang H, Yao T, Wang W, et al: Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thorac Surg 2003;76:136-140.
18. Davenport A: Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis 2001;37:457-466.
19. Yekebas EF, Eisenberger CF, Ohnesorge H, et al: Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 2001;29:1423-1430.
20. Rabindranath K, Adams J, Macleod A, Muirhead N: Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007;CD003773.
21. Tarakçioǧlu M, Erbaǧci AB, Usalan C, et al: Acute effect of hemodialysis on serum levels of the proinflammatory cytokines. Mediators Inflamm 2003;12:15-19.
22. Lonnemann G, Bechstein M, Linnenweber S, et al: Tumor necrosis factor-α during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int Suppl 1999;(72):S84-S87.
23. Brunet S, Leblanc M, Geadah D, et al: Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999;34:486-492.
24. Bouman CS, Oudemans-van Straaten HM, Schultz MJ, Vroom MB: Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing. J Crit Care 2007;22:1-12.
25. Laurent I, Adrie C, Vinsonneau C, et al: High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005;46:432-437.
26. Cruz DN, Bellomo R, Ronco C: Clinical effects of polymyxin B-immobilized fiber column in septic patients. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 444-451.
27. Cruz DN, Perazella MA, Bellomo R, et al: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007;11:R47.
28. Uchino S, Bellomo R, Goldsmith D, et al: Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med 2002;28:651-655.
29. Morgera S, Haase M, Rocktaschel J, et al: High permeability haemofiltration improves peripheral blood mononuclear cell proliferation in septic patients with acute renal failure. Nephrol Dial Transplant 2003;18:2570-2576.
30. Lee PA, Weger GW, Pryor RW, Matson JR: Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 1998;26:730-737.
31. Morgera S, Haase M, Kuss T, et al: Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006;34:2099-2104.
32. Haase M, Bellomo R, Baldwin I, et al: Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial. Am J Kidney Dis 2007;50:296-304.
33. Peng ZY, Kiss JE, Cortese-Hasset A, et al: Plasma filtration on mediators of thrombotic microangiopathy: an in vitro study. Int J Artif Organs 2007;30:401-406.
34. Bengsch S, Boos KS, Nagel D, et al: Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: clinical results of a pilot study. Shock 2005;23:494-500.
35. Formica M, Inguaggiato P, Bainotti S, Wratten ML: Coupled plasma filtration adsorption. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 405-410.
36. Bellomo R, Tetta C, Ronco C: Coupled plasma filtration adsorption. Intensive Care Med 2003;29:1222-1228.
37. Ronco C, Brendolan A, Lonnemann G, et al: A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002;30:1250-1255.
38. Clark WF, Rock GA, Buskard N, et al: Therapeutic plasma exchange: an update from the Canadian Apheresis Group. Ann Intern Med 1999;131:453-462.
39. Nguyen TC, Carcillo JA: Bench-to-bedside review: thrombocytopenia- associated multiple organ failure - a newly appreciated syndrome in the critically ill. Crit Care 2006;10:235.
40. Uchino S, Bellomo R, Morimatsu H, et al: Continuous renal replacement therapy: a worldwide practice survey: The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Intensive Care Med 2007;33:1563-1570.
41. Uchino S, Bellomo R, Kellum JA, et al: Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs 2007;30:281-292.